Meet the CSEP Team Series: Alexandra Smetanina

Meet Alexandra Smetanina, a first-year doctoral student in Design Engineering and a Lord Sainsbury PhD scholar at CSEP.

Meet Alexandra Smetanina, a first-year doctoral student in Design Engineering and a Lord Sainsbury PhD scholar at CSEP.

In this series, we speak with our partner institutions about the collaborations shaping research and policy. In this post, we explore the partnership between CSEP and the Centre for Emerging Technology and Security focused on UK AI assurance marketplace.
Author: James Barlow
For years, the UK has traded on its reputation as a “life sciences powerhouse.” This narrative isn’t entirely false: we have world-class universities, our basic science is strong, and the NHS provides a unique testbed for clinical research. Yet behind the rhetoric, the biopharma sector is facing real and immediate challenges.
The government has placed growth at the heart of its mission and in June of this year published its Industrial Strategy. One important issue raised by the Industrial Strategy is the need to better understand the relationship between national sector strategies and the regional areas where firms are located.
The high-level Sector Plans identified the most important city regions and clusters for the given sector. In addition, regional authorities are developing ambitious Local Growth Plans which are supposed to dovetail with the Industrial Strategy Sector Plans. These local plans need to tackle the critical issues that are constraining growth across sectors including poor transport connections, skills shortages and housing.